U.S. markets closed

Autolus Therapeutics plc (AUTL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.42-0.18 (-3.21%)
At close: 4:00PM EDT

5.29 -0.13 (-2.40%)
After hours: 6:33PM EDT

Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 4/11/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 1.71
52-Week Change 3-31.54%
S&P500 52-Week Change 345.07%
52 Week High 317.19
52 Week Low 35.10
50-Day Moving Average 36.31
200-Day Moving Average 39.02

Share Statistics

Avg Vol (3 month) 3837.43k
Avg Vol (10 day) 3279.08k
Shares Outstanding 570.51M
Implied Shares Outstanding 6N/A
Float 33.9M
% Held by Insiders 125.58%
% Held by Institutions 118.05%
Shares Short (Mar 14, 2021) 43.7M
Short Ratio (Mar 14, 2021) 43.33
Short % of Float (Mar 14, 2021) 4N/A
Short % of Shares Outstanding (Mar 14, 2021) 45.25%
Shares Short (prior month Feb 11, 2021) 41.71M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2018


Profit Margin 0.00%
Operating Margin (ttm)-6,570.75%

Management Effectiveness

Return on Assets (ttm)-22.27%
Return on Equity (ttm)-29.62%

Income Statement

Revenue (ttm)1.08M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-133.17M
EBITDA -68.94M
Net Income Avi to Common (ttm)-53.28M
Diluted EPS (ttm)-1.40
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)217.45M
Total Cash Per Share (mrq)5.52
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)11.05
Book Value Per Share (mrq)5.91

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A